TrialJournal of neuro-oncology2018

Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.

Niamh Coleman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.